Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:403-404 (23 February), doi:10.1136/bmj.39493.418704.1F
| The first 150 words of the full text of this article appear below. |
Bolland et al did not control for vitamin D concentrations during their study but said only that the women with serum 25-hydroxyvitamin D concentrations below 25 nmol/l were excluded.1 This implies that serum concentrations of vitamin D were not monitored during the study. This is important because, according to the results of the Framingham offspring study, low serum concentrations of vitamin D are strictly associated with an increase in vascular risk2 and may impair calcium absorption.2
Two important confounding factors are not controlled for—consumption of non-steroidal anti-inflammatory drugs and analgesics and previous hormone replacement therapy. These two potent confounders may completely reverse the results and also interact with each other on cardiovascular risk.3 4 5
To consider the self reported events separately from those unreported but taken from the national database of hospital admissions is surprising. When self reported and unreported events are considered together the differences between calcium and placebo group
Luca Puccetti, president
1 Promed Galileo Medical Society, Pisa 56011, Italy
lucpucce@promedgalileo.org